Registry for assessing coronary artery anomalies
Registry for Invasive and Non-invasive Anatomical Assessment and Outcome of Coronary Artery Anomalies
This study looks at patients with unusual heart arteries to see how common they are and how they might affect heart health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 2 sites (Bern and 1 other locations) |
| Trial ID | NCT04475289 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the anatomical characteristics and outcomes of patients with anomalous coronary arteries (ACA). It focuses on the prevalence and clinical significance of various types of ACA, particularly those with an interarterial course, which can lead to serious cardiac events. The study utilizes advanced imaging techniques and hemodynamic assessments to determine the relevance of these anomalies in patients undergoing clinically indicated testing. By establishing a specialized clinic, the study seeks to improve understanding and management of coronary artery anomalies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with diagnosed coronary artery anomalies requiring clinical evaluation.
Not a fit: Patients without coronary artery anomalies or those not requiring clinical testing will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and treatment of patients with coronary artery anomalies, potentially reducing the risk of adverse cardiac events.
How similar studies have performed: While studies on coronary artery anomalies exist, this specific registry approach focusing on anatomical assessment and outcomes is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years. * CAA with a clinically indicated testing (noninvasive and/or invasive measurement) at our institution * Informed consent Exclusion Criteria: \- None
Where this trial is running
Bern and 1 other locations
- University Hospital Inselspital, Bern — Bern, Switzerland (Recruiting)
- University Hospital, Zürich — Zurich, Switzerland (Recruiting)
Study contacts
- Principal investigator: Christoph Gräni, MD PhD — Inselspital, Bern University Hospital
- Study coordinator: Christoph Gräni, MD PhD
- Email: christoph.graeni@insel.ch
- Phone: +41 31 632 4508
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.